GlassScriptPhysician profile
Kim Hoang
NPI 1730455155
$1,717.30
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,674 · 2020: $43.13.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $403.46 | 2019 | |
| Vertos Medical, INC. | $337.49 | 2019 | |
| Boston Scientific Corporation | $274.22 | 2019-2020 | |
| Pacira Therapeutics, INC. | $148.17 | 2019 | |
| Pfizer INC. | $119.66 | 2019 | |
| Medtronic USA, INC. | $108.57 | 2019 | |
| Kaleo, INC. | $39.28 | 2019 | |
| Vertical Pharmaceuticals, LLC | $37.04 | 2019 | |
| Biodelivery Sciences International, INC. | $36.42 | 2019 | |
| Scilex Pharmaceuticals INC. | $30.30 | 2019-2020 | |
| Shionogi INC | $29.04 | 2019 | |
| Collegium Pharmaceutical, INC. | $28.48 | 2019 | |
| Amgen INC. | $23.71 | 2019 | |
| Horizon Therapeutics Plc | $20.65 | 2019 | |
| Bioventus LLC | $19.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $19.18 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.96 | 2019 | |
| Daiichi Sankyo INC. | $10.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.